Who owns ORUKA THERAPEUTICS INC?
- Ticker: ORKA
- CUSIP Number: 687604108
Tip: Access positions for across all investors
Analyze quarterly positions in Oruka Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Oruka Therapeutics stock
Who bought or sold ORUKA THERAPEUTICS INC this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| FMR | 5.5M | $107M | 18% | Dec 2024 |
|
| Fairmount Funds Management | 3.4M | $65M | 5% | Dec 2024 |
|
| VR Adviser | 3.3M | $64M | 6% | Dec 2024 |
|
| Rtw Investments | 1.9M | $38M | 5% | Dec 2024 |
|
| Vanguard Group | 1.6M | $31M | 4161% | Dec 2024 |
|
| Commodore Capital | 1.4M | $28M | 4% | Dec 2024 |
|
| T. Rowe Price Associates | 1.3M | $26M | 374% | Dec 2024 |
|
| Braidwell | 1.1M | $27M | 123% | Dec 2024 |
|
| Henderson Group | 849k | $16M | 260% | Dec 2024 |
|
| Perceptive Advisors | 846k | $16M | -32% | Dec 2024 |
|
| Paradigm Biocapital Advisors | 820k | $16M | 14% | Dec 2024 |
|
| BlackRock | 751k | $15M | 3384% | Dec 2024 |
|
| Deep Track Capital | 750k | $15M | -39% | Dec 2024 |
|
| Franklin Resources | 721k | $14M | 0% | Dec 2024 |
|
| Frazier Life Sciences Management | 583k | $11M | 22% | Dec 2024 |
|
| Polar Capital Holdings | 550k | $11M | 100% | Dec 2024 |
|
| Sr One Capital Management | 430k | $8.3M | 15% | Dec 2024 |
|
| Redmile Group | 412k | $8.0M | 0% | Dec 2024 |
|
| Morgan Stanley | 406k | $7.9M | 496% | Dec 2024 |
|
| Woodline Partners | 391k | $7.6M | 0% | Dec 2024 |
|
| Affinity Asset Advisors | 369k | $7.1M | 5% | Dec 2024 |
|
| Point72 Asset Management | 361k | $7.0M | -25% | Dec 2024 |
|
| Avidity Partners Management | 352k | $6.8M | -55% | Dec 2024 |
|
| Leucadia National Corporation | 350k | $6.8M | 100% | Dec 2024 |
|
| Geode Capital Management | 342k | $6.6M | 2349% | Dec 2024 |
|
| Cable Car Capital | 333k | $6.5M | 0% | Dec 2024 |
|
| Driehaus Capital Management | 309k | $6.0M | 0% | Dec 2024 |
|
| Blackstone Group | 240k | $4.7M | 100% | Dec 2024 |
|
| Dr. Jeffrey R. Jay, M.D. | 229k | $4.4M | -56% | Dec 2024 |
|
| Qube Research & Technologies | 152k | $2.9M | 268% | Dec 2024 |
|
| Wellington Management Company | 95k | $1.8M | 16% | Dec 2024 |
|
| TD Asset Management | 95k | $1.8M | 0% | Dec 2024 |
|
| Barclays | 75k | $1.4M | 100% | Dec 2024 |
|
| Adage Capital Partners GP | 69k | $1.3M | -65% | Dec 2024 |
|
| Northern Trust | 64k | $1.2M | 100% | Dec 2024 |
|
| Kennedy Capital Management | 61k | $1.2M | 100% | Dec 2024 |
|
| Toronto-Dominion Bank | 58k | $1.1M | 100% | Dec 2024 |
|
| Manufacturers Life Insurance Company | 42k | $820k | 0% | Dec 2024 |
|
| Weiss Asset Management LP[1 | 40k | $776k | 100% | Dec 2024 |
|
| 683 Capital Management | 34k | $657k | 100% | Dec 2024 |
|
| Millennium Management | 30k | $588k | 100% | Dec 2024 |
|
| UBS Group | 25k | $488k | 100% | Dec 2024 |
|
| State Street Corporation | 25k | $485k | 100% | Dec 2024 |
|
| Ensign Peak Advisors | 25k | $485k | 0% | Dec 2024 |
|
| OMERS Administration Corporation | 20k | $384k | 100% | Dec 2024 |
|
| Jane Street | 18k | $343k | 100% | Dec 2024 |
|
| Charles Schwab Investment Management | 16k | $303k | 100% | Dec 2024 |
|
| Squarepoint Ops | 12k | $236k | 100% | Dec 2024 |
|
| Citigroup | 8.0k | $156k | -70% | Dec 2024 |
|
| China Universal Asset Management | 7.4k | $144k | 100% | Dec 2024 |
|
| AlphaCentric Advisors | 6.1k | $119k | 100% | Dec 2024 |
|
| Jpmorgan Chase & Co | 2.8k | $54k | 100% | Dec 2024 |
|
| Mirae Asset Global Investments | 1.2k | $22k | 100% | Dec 2024 |
|
| Gf Fund Management | 735.00 | $14k | 100% | Dec 2024 |
|
| Tower Research Capital | 584.00 | $11k | -39% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 468.00 | $9.1k | 100% | Dec 2024 |
|
| Bank of America Corporation | 198.00 | $3.8k | 1220% | Dec 2024 |
|
| Activest Wealth Management | 166.00 | $3.2k | 0% | Dec 2024 |
|
| Daiwa Securities Group | 116.00 | $2.0k | 100% | Dec 2024 |
|
| Royal Bank of Canada | 55.00 | $1.2k | 100% | Dec 2024 |
|
| Group One Trading | 23.00 | $445.999900 | 100% | Dec 2024 |
|
| Parallel Advisors | 20.00 | $205.000000 | 0% | Mar 2025 |
|
| National Bank Of Canada /fi/ | 8.00 | $155.000000 | 100% | Dec 2024 |
|
Who sold out of Oruka Therapeutics?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
|---|---|---|---|
| Logos Global Management | Sep 2024 | 257k | $6.3M |
| Cowen And Company | Sep 2024 | 58k | $1.4M |
| Susquehanna International | Sep 2024 | 13k | $306k |
| ADAR1 Capital Management | Sep 2024 | 11k | $274k |
| New England Capital Financial Advisors | Sep 2024 | 41.00 | $1.0k |